1921
Volume 98, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Seasonal malaria chemoprevention (SMC) for children < 5 is a strategy that is gaining popularity in West African countries. Although its efficacy to reduce malaria incidence has been demonstrated in trials, the effects of SMC implemented in routine program conditions, outside of experimental contexts, are unknown. In 2014 and 2015, a survey was conducted in 1,311 households located in Kaya District (Burkina Faso) where SMC had been recently introduced. All children < 72 months were tested for malaria and anemia. A pre–post study with control group was designed to measure SMC impact during high transmission season. A difference-in-differences approach was coupled in the analysis with propensity score weighting to control for observable and time-invariant nonobservable confounding factors. SMC reduced the parasitemia point and period prevalence by 3.3 and 24% points, respectively; this translated into protective effects of 51% and 62%. SMC also reduced the likelihood of having moderate to severe anemia by 32%, and history of recent fever by 46%. Self-reported coverage for children at the first cycle was 83%. The SMC program was successfully added to a package of interventions already in place. To our knowledge, with prevalence < 10% during the peak of the transmission season, this is the first time that malaria can be reported as hypo-endemic in a sub-Sahelian setting in Burkina Faso. SMC has great potential, and along with other interventions, it could contribute to approaching the threshold where elimination strategies will be envisioned in Burkina Faso.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.17-0599
2018-02-07
2018-11-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/98/2/tpmd170599.html?itemId=/content/journals/10.4269/ajtmh.17-0599&mimeType=html&fmt=ahah

References

  1. Geiger C, Agustar HK, Compaore G, Coulibaly B, Sie A, Becher H, Lanzer M, Janisch T, , 2013. Declining malaria parasite prevalence and trends of asymptomatic parasitaemia in a seasonal transmission setting in north-western Burkina Faso between 2000 and 2009–2012. Malar J 12: 27.
  2. Murray C, Rosenfeld L, Lim S, Andrews K, Foreman K, Haring D, Fullman N, Naghavi M, Lozano R, Lopez A, , 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413431.
  3. WHO, 2015. World Malaria Report 2015. Geneva, Switzerland: World Health Organization.
  4. WHO, 2016. World Health Statistics 2016: Monitoring Health for the SDGs. Geneva, Switzerland: World Health Organization.
  5. Ye Y, Louis VR, Simboro S, Sauerborn R, , 2007. Effect of meteorological factors on clinical malaria risk among children: an assessment using village-based meteorological stations and community-based parasitological survey. BMC Public Health 7: 101.
  6. Y, , 2008. Environmental Factors and Malaria Transmission Risk: Modelling the Risk in a Holoendemic Area of Burkina Faso. Aldershot, United Kingdom: Ashgate.
  7. Ramroth H, Ndugwa RP, Muller O, Ye Y, Sie A, Kouyate B, Becher H, , 2009. Decreasing childhood mortality and increasing proportion of malaria deaths in rural Burkina Faso. Glob Health Action 2: pi: 1909.
  8. Ouedraogo A, 2013. Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso. PLoS One 8: e50036.
  9. Ministère de la Santé, 2017. Annuaire Statistique 2016. Ouagadougou, Burkina Faso: Ministère de la Santé du Burkina Faso.
  10. Noor AM, Kibuchi E, Mitto B, Coulibaly D, Doumbo OK, Snow RW, , 2015. Sub-national targeting of seasonal malaria chemoprevention in the Sahelian countries of the Nouakchott initiative. PLoS One 10: e0136919.
  11. WHO, 2013. Seasonal Malaria Chemoprevention with Sulfadoxine–Pyrimethamine Plus Amodiaquine in Children: A Field Guide. Geneva, Switzerland: World Health Organization.
  12. Cairns M, Roca-Feltrer A, Garske T, Wilson A, Diallo D, Milligan P, Ghani A, Greenwood AM, , 2012. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nature 3: 881.
  13. Greenwood B, , 2006. Review: intermittent preventive treatment—a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health 11: 983991.
  14. Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C, , 2012. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev 2: CD003756.
  15. Wilson AL, Taskforce IP, , 2011. A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS One 6: e16976.
  16. Dicko A, 2011. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med 8: e1000407.
  17. Konate AT, 2011. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. PLoS Med 8: e1000408.
  18. Cissé B, 2006. Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 367: 659667.
  19. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B, Chandramohan D, , 2008. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One 3: e4000.
  20. Ntab B, 2007. Impact of intermittent preventive anti-malarial treatment on the growth and nutritional status of preschool children in rural Senegal (west Africa). Am J Trop Med Hyg 77: 411417.
  21. Sokhna C, 2008. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One 3: e1471.
  22. Bojang K, Akor F, Bittaye O, Conway D, Bottomley C, Milligan P, Greenwood B, , 2010. A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children. PLoS One 5: e11225.
  23. Zongo I, Milligan P, Compaore YD, Some AF, Greenwood B, Tarning J, Rosenthal PJ, Sutherland C, Nosten F, Ouedraogo JB, , 2015. Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for seasonal malaria chemoprevention in Burkina Faso. Antimicrob Agents Chemother 59: 43874396.
  24. Patouillard E, Conteh L, Webster J, Kweku M, Chandramohan D, Greenwood B, , 2011. Coverage, adherence and costs of intermittent preventive treatment of malaria in children employing different delivery strategies in Jasikan, Ghana. PLoS One 6: e24871.
  25. Bojang KA, Akor F, Conteh L, Webb E, Bittaye O, Conway DJ, Jasseh M, Wiseman V, Milligan PJ, Greenwood B, , 2011. Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med 8: e1000409.
  26. Buffet PA, Briand V, Renia L, Thellier M, Danis M, Mazier D, , 2008. Intermittent preventive antimalarial treatment to children (IPTc): firebreak or fire trap? Trends Parasitol 24: 482485, discussion 485–486.
  27. Beeson JG, Rogerson SJ, Mueller I, Richards JS, Fowkes FJ, , 2011. Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and delivery. PLoS Med 8: e1000410.
  28. Barreto ML, , 2005. Efficacy, effectiveness, and the evaluation of public health interventions. J Epidemiol Community Health 59: 345346.
  29. WHO, 2017. Malaria Prevention Works: Let’s Close the Gap. Geneva, Switzerland: World Health Organization.
  30. Some AF, Zongo I, Compaore YD, Sakande S, Nosten F, Ouedraogo JB, Rosenthal PJ, , 2014. Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso. Antimicrob Agents Chemother 58: 36603665.
  31. Seogo H, 2016. Impact de la Chimioprévention du Paludisme Saisonnier dans le District de Séguénéga, Burkina Faso, 2013–2015. Roll Back Malaria Communication Community of Practice 3rd Annual Meeting, Dakar, Senegal, September 28, 2016.
  32. Naidoo I, Roper C, , 2011. Drug resistance maps to guide intermittent preventive treatment of malaria in African infants. Parasitology 138: 14691479.
  33. Shadish W, Cook T, Campbell D, , 2001. Experimental and Quasi-Experimental Designs for Generalized Causal Inferences. Boston, MA: Houghton Mifflin.
  34. Kouanda S, Bado A, Yameogo M, Nitiema J, Yameogo G, Bocoum F, Millogo T, Ridde V, Haddad S, Sondo B, , 2013. The Kaya HDSS, Burkina Faso: a platform for epidemiological studies and health programme evaluation. Int J Epidemiol 42: 741749.
  35. Ibrahim B, Polcher J, Karambiri H, Rockel B, , 2012. Characterization of the rainy season in Burkina Faso and it’s representation by regional climate models. Clim Dyn 39: 12871302.
  36. Druetz T, Fregonese F, Bado A, Millogo T, Kouanda S, Diabate S, Haddad S, , 2015. Abolishing fees at health centers in the context of community case management of malaria: what effects on treatment-seeking practices for febrile children in rural Burkina Faso? PLoS One 10: e0141306.
  37. Maltha J, Guiraud I, Lompo P, Kabore B, Gillet P, Van Geet C, Tinto H, Jacobs J, , 2014. Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso. Malar J 13: 20.
  38. Druetz T, Ridde V, Kouanda S, Ly A, Diabate S, Haddad S, , 2015. Utilization of community health workers for malaria treatment: results from a three-year panel study in the districts of Kaya and Zorgho, Burkina Faso. Malar J 14: 71.
  39. WHO, 2011. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva, Switzerland: World Health Organization.
  40. Gatton ML, Rees-Channer RR, Glenn J, Barnwell JW, Cheng Q, Chiodini PL, Incardona S, Gonzalez IJ, Cunningham J, , 2015. Pan-Plasmodium band sensitivity for Plasmodium falciparum detection in combination malaria rapid diagnostic tests and implications for clinical management. Malar J 14: 115.
  41. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P, , 2011. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev 7: CD008122.
  42. Wilson ML, , 2012. Malaria rapid diagnostic tests. Clin Infect Dis 54: 16371641.
  43. Swarthout TD, Counihan H, Senga RK, van den Broek I, , 2007. Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Malar J 6: 58.
  44. Maltha J, Gillet P, Jacobs J, , 2013. Malaria rapid diagnostic tests in endemic settings. Clin Microbiol Infect 19: 399407.
  45. WHO, 2015. Malaria Rapid Diagnostic Test Performance: Results of WHO Product Testing of Malaria RDTs: Round 6 (2014–2015). Geneva, Switzerland: World Health Organization.
  46. Eisele TP, Miller JM, Moonga HB, Hamainza B, Hutchinson P, Keating J, , 2011. Malaria infection and anemia prevalence in Zambia’s Luangwa District: an area of near-universal insecticide-treated mosquito net coverage. Am J Trop Med Hyg 84: 152157.
  47. Roll Back Malaria, 2008. Malaria Indicators Surveys: Protocols and Methods. Geneva, Switzerland: Roll Back Malaria Partnership. Available at: http://malariasurveys.org/toolkit.cfm. Accessed January 15, 2015.
  48. Fregonese F, Siekmans K, Kouanda S, Druetz T, Ly A, Diabate S, Haddad S, , 2017. Impact of contaminated household environment on stunting in children aged 12–59 months in Burkina Faso. J Epidemiol Community Health 71: 356363.
  49. Rubin DB, , 1990. Neyman (1923) and causal inference in experiments and observational studies. Stat Sci 5: 472480.
  50. Angrist JD, Pischke J-S, , 2015. Mastering ‘Metrics: The Path from Cause to Effect. Princeton, NJ: Princeton University Press.
  51. Galasso E, Ravallion M, , 2004. Social protection in a crisis: Argentina’s plan Jefes y Jefas. World Bank Econ Rev 18: 367399.
  52. Heckman JJ, Ichimura H, Todd PE, , 1997. Matching as an econometric evaluation estimator: evidence from evaluating a job training programme. Rev Econ Stud 64: 605654.
  53. Cummings P, , 2009. Methods for estimating adjusted risk ratios. Stata J 9: 175196.
  54. Janani L, Mansournia MA, Nourijeylani K, Mahmoodi M, Mohammad K, , 2015. Statistical issues in estimation of adjusted risk ratio in prospective studies. Arch Iran Med 18: 713719.
  55. Barros AJ, Hirakata VN, , 2003. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21.
  56. Freedman DA, Berk RA, , 2008. Weighting regressions by propensity scores. Eval Rev 32: 392409.
  57. Zou G, , 2004. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159: 702706.
  58. Stuart EA, Huskamp HA, Duckworth K, Simmons J, Song Z, Chernew M, Barry CL, , 2014. Using propensity scores in difference-in-differences models to estimate the effects of a policy change. Health Serv Outcomes Res Methodol 14: 166182.
  59. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T, , 2006. Variable selection for propensity score models. Am J Epidemiol 163: 11491156.
  60. Rubin DB, Thomas N, , 1996. Matching using estimated propensity scores: relating theory to practice. Biometrics 52: 249264.
  61. Gertler P, World Bank; , 2016. Impact Evaluation in Practice. Washington, DC: World Bank Group.
  62. Jones AM, , 2007. Identification of treatment effects in health economics. Health Econ 16: 11271131.
  63. Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal PJ, Brooker SJ, Staedke SG, Kamya MR, , 2014. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis 58: 14041412.
  64. Kassebaum NJ, 2014. A systematic analysis of global anemia burden from 1990 to 2010. Blood 123: 615624.
  65. McCaffrey DF, Ridgeway G, Morral AR, , 2004. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 9: 403425.
  66. Janin P, , 2004. Gestion spatio-temporelle de la soudure alimentaire dans le Sahel Burkinabé. Tiers Monde 4: 909933.
  67. Diabate S, Druetz T, Millogo T, Ly A, Fregonese F, Kouanda S, Haddad S, , 2015. Domestic larval control practices and malaria prevalence among under-five children in Burkina Faso. PLoS One 10: e0141784.
  68. Diabaté S, Druetz T, Bonnet E, Kouanda S, Ridde V, Haddad S, , 2014. Insecticide-treated nets ownership and utilization among under-five children following the 2010 mass distribution in Burkina Faso. Malar J 13: 353.
  69. Ridde V, Druetz T, Poppy S, Kouanda S, Haddad S, , 2013. Implementation fidelity of the national malaria control program in Burkina Faso. PLoS One 8: e69865.
  70. Druetz T, Kadio K, Haddad S, Kouanda S, Ridde V, , 2015. Do community health workers perceive mechanisms associated with the success of community case management of malaria? A qualitative study from Burkina Faso. Soc Sci Med 124: 232240.
  71. Druetz T, Ridde V, Haddad S, , 2014. The divergence between community case management of malaria and renewed calls for primary healthcare. Crit Public Health 25: 165177.
  72. Hay SI, Smith DL, Snow RW, , 2008. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 8: 369378.
  73. Hay SI, 2009. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 6: e1000048.
  74. O’Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CR, Marsh K, , 2008. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 372: 15551562.
  75. Carneiro I, Roca-Feltrer A, Griffin JT, Smith L, Tanner M, Schellenberg JA, Greenwood B, Schellenberg D, , 2010. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One 5: e8988.
  76. Nankabirwa J, Brooker SJ, Clarke SE, Fernando D, Gitonga CW, Schellenberg D, Greenwood B, , 2014. Malaria in school-age children in Africa: an increasingly important challenge. Trop Med Int Health 19: 12941309.
  77. Cissé B, 2016. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med 13: e1002175.
  78. Yin RK, , 2009. Case Study Research: Design and Methods. Los Angeles, CA: Sage.
  79. Grembowski D, , 2001. The Practice of Health Program Evaluation. Thousand Oaks, CA: Sage.
  80. Rossi PH, Lipsey MW, Freeman HE, , 2004. Evaluation: A Systematic Approach. Thousand Oaks, CA: Sage.
  81. Tagbor H, Antwi GD, Acheampong PR, Bart Plange C, Chandramohan D, Cairns M, , 2016. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial. Trop Med Int Health 21: 224235.
  82. Bigira V, 2014. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial. PLoS Med 11: e1001689.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0599
Loading
/content/journals/10.4269/ajtmh.17-0599
Loading

Data & Media loading...

Supplementary Data

Supplemental Table

  • Received : 27 Jul 2017
  • Accepted : 14 Nov 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error